Some studies have suggested that morning is the optimal time for immunotherapy, but a new analysis of patients with lung cancer begs to differ.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/morning-immunotherapy-does-not-boost-lung-cancer-survival-2026a10009qx?src=rss
Author :
Publish date : 2026-03-31 09:42:00
Copyright for syndicated content belongs to the linked Source.
